Navigation Links
Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
Date:5/15/2008

3.5 hours. In seven out of 20 cases (35 percent), DP-PS correctly predicted the eventual outcome. These results seem to indicate that PS derived from DP model showed better correlation with drug exposure and could predict patient outcome better than Ktrans.

In a separate analysis, the effects of ABT-869 on biomarkers of angiogenesis were evaluated. Correlations of dose and pharmacokinetics of ABT-869, with serum biomarkers, tumor DCE-MRI tracer kinetics, proteinuria and hypertension were assessed. Results appeared to indicate that ABT-869 induced dose-dependent changes in serum biomarkers are consistent with anti-angiogenic activity. However, these serum biomarkers had limited value in predicting safety, i.e., proteinuria or hypertension. The utility of tumor flow and permeability changes on DCE-MRI in predicting proteinuria should be further examined. Updated information will be presented at the ASCO Annual Meeting.

Background on Abbott's Oncology Pipeline

Bcl-2 Family Protein Inhibitors (ABT-263)

Researchers have been interested in the Bcl-2 family of proteins since their role in preventing apoptosis -- the natural process by which damaged or unwanted cells die and are cleared from the body -- was proven more than a decade ago. Discovered by Abbott scientists, ABT-263 restores programmed cell death, a natural mechanism for the elimination of cancerous cells, by inhibiting the function of Bcl-2 proteins.

Bcl-2 proteins play a central role in regulating apoptosis, as well as tumor formation, tumor growth and resistance to treatment. Pioneering work in structural biology at Abbott established how the Bcl-2 family proteins interact with one another, leading researchers to develop a novel compound that causes cancer cells to self-destruct.

ABT-263 is in Phase I/II clinical trials for lymphomas and solid tumors, including small cell lung cancer. Preclinical data has shown that Abbott's Bcl-2 family protein inhibitors bind to Bc
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Abbott to Present at Citi Investment Research Global Health Care Conference
2. Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
3. Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
4. Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
5. Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
6. Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
7. Abbott Hosts Conference Call for First-Quarter Earnings
8. Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
9. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
10. Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
11. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... The Doctors on Liens mission for over ... attorneys with the best doctors working on a lien basis. ... their history and that trend continues with the addition of ... in the Tujunga / Sunland area. Featuring ... can find comprehensive care and detailed documentation of their injuries. ...
(Date:4/27/2015)... Sitting or standing for long periods of time can ... those whose occupation requires them to be sitting while they ... to be on their feet for most of the day, ... severe and longer lasting. These people suffer from a condition ... Northeast Houston Vein Center is offering tips on how to ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Data Integrity ... Within Your Operations or Your Partners/Suppliers, **FDAnews Webinar**, May ... http://www.fdanews.com/DataIntegrity , Data integrity issues have become ... few years., Uncovering data integrity issues within manufacturing operations ... integrity issues come to light, remediating them can be ...
(Date:4/27/2015)... Columbus, OH (PRWEB) April 27, 2015 ... insurance to help his clients feel secure, but also helps ... a.m. to 7 p.m., Douglas will be manning a booth ... Expo Center, Lausche Building, 717 E. 17th Ave., Columbus, Ohio. ... this worthy event that will feature hundreds of adoptable pets ...
(Date:4/27/2015)... A' Design Award and Competition is pleased ... by Boombang Inc Design Team has been announced as ... Scientific Instruments, Medical Devices and Research Equipment Design ... Boombang Inc Design Team, the creative team behind the ... Image Lumica is a two-way communication device between patients ...
Breaking Medicine News(10 mins):Health News:Prominent Doctors with Distinguished Backgrounds Join Doctors on Liens in Tujunga 2Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 2Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 3Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 3Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 4Health News:Farmers Insurance Agent Douglas Fitzpatrick Ensures Pets Find Homes 2Health News:Boombang Inc Design Team wins Platinum in A' Medical Product Design Awards 2
... prevalence of leprosy is decreasing to about 0.95 cases per ... is eliminated from India. // But this statement is very ... completely eliminated but the prevalence is significantly reduced. It is ... 10,000 population. ,In India Delhi has a high ...
... feel good when they are complimented on their age. It is ... // life with loads of money minus the worries. It is ... and drink heavily. ,This study mainly aims in understanding ... on the way men and women age. It is very astonishing ...
... number of dentists who graduate from the dental schools stay in ... rise and the health officials fear that his is due to ... ,Many dental graduates are out of job due to this ... the dental graduates who left Scotland to find work elsewhere but ...
... that consumption of fish oil can counteract the effect of ... health. // The results of the present study have valuable ... ,The study participants were required to consume a ... months. Those who consumed soy oil supplements formed the control ...
... potential of stem cells in the repair and treatment ... stem cells from muscle tissue // of injured rats ... a therapeutic protein (bone morphogenetic protein 4, BMP-4, capable ... a repair mechanism can be instituted in humans as ...
... based Vancouver Company Copeman Healthcare Inc.’s may face charges ... to charge an initial consultation fee of $3,500. // ... memorandum to the Health ministry to take action against ... based treatment and recommends universal rate for all treatment. ...
Cached Medicine News:Health News:Lifestyle plays an important role in determining one’s ag 2Health News:Shortage of dentists in Scotland 2Health News:Muscle Derived Stem Cell Can Repair Damaged Cartilage 2
(Date:4/27/2015)... MALVERN, Pa. , April 27, 2015 /PRNewswire/ ... development and commercialization of products focused on the ... executive team of William Stewart and ... mark important steps in SCILEX,s proprietary drug development ... of its products. The Company,s first product, ZTlido™ ...
(Date:4/27/2015)... 27, 2015 Harwood Feffer LLP ( www.hfesq.com ... directors of Aerie Pharmaceuticals, Inc. ("Aerie" or the "Company") ... breached its fiduciary duties to shareholders. On ... announcing results from its first Phase 3 registration trial ... that in the trial, Rhopressa failed to meet its ...
(Date:4/27/2015)... 27, 2015 Bronstein, Gewirtz & Grossman, LLC ... the securities of Celladon Corporation ("Celladon" or the "Company") ... Peretz Bronstein or his investor relations coordinator ... 212-697-6484. The investigation concerns whether Celladon and ... 10(b) and 20(a) of the Securities Exchange Act of ...
Breaking Medicine Technology:SCILEX Pharmaceuticals Announces Commercial Executive Appointments 2SCILEX Pharmaceuticals Announces Commercial Executive Appointments 3Harwood Feffer LLP Announces Investigation of Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Celladon Corporation 2
... March 06, 2007 /PRNewswire/ -- Up to two ... up to 600,000,hospitalized. Its primary complication, pulmonary embolism ... than breast cancer and,AIDS combined. People who suffer ... DVT, because these factors also heighten the,likelihood of ...
... POZEN Inc.,(NASDAQ: POZN), today announced top-line results of its ... of 2006. PA 325 is a patented formulation of ... immediate release,formulation of a proton pump inhibitor., The PA ... subjects,over the age of 50. Each subject was treated ...
Cached Medicine Technology:DVT Awareness Survey Findings: Heart and Respiratory Patients 2POZEN Announces Positive Outcome for PA 325 Proof of Concept Study 2POZEN Announces Positive Outcome for PA 325 Proof of Concept Study 3
Radianse indoor positioning supports healthcare asset management with a way to locate medical equipment, devices and other portable assets....
Agility has delivered a RFID-enabled mobile asset management program....
Agility can provide tracking and management of surgical instruments, instrument trays and case carts to significantly enhance the current central sterile department flow by improving efficiency....
Assetrac allows identification, location, and protection of your assets....
Medicine Products: